Abeona Therapeutics Dirección
Dirección controles de criterios 2/4
El CEO de Abeona Therapeutics' es Vish Seshadri , nombrado en Oct 2021, tiene una permanencia de 2.5 años. compensación anual total es $2.85M, compuesta por 19.5% salario y 80.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.93% de las acciones de la empresa, por valor de $1.69M. La antigüedad media del equipo directivo y de la junta directiva es de 2.4 años y 3.1 años, respectivamente.
Información clave
Vish Seshadri
Chief Executive Officer (CEO)
US$2.8m
Compensación total
| Porcentaje del salario del CEO | 19.5% |
| Permanencia del CEO | 2.6yrs |
| Participación del CEO | 2.0% |
| Permanencia media de la dirección | 2.5yrs |
| Promedio de permanencia en la Junta Directiva | 3.2yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
May 01
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate
Jan 04Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
Aug 16Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?
Mar 31Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value
Oct 19Abeona Therapeutics stock continues recent strong run, shares rise ~10%
Oct 04Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M
Aug 11Abeona therapeutics regains compliance with Nasdaq minimum bid price requirement
Jul 20Abeona crashes 21% as reverse stock split takes effect
Jul 05Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely
Mar 02Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money
Aug 17Abeona Therapeutics shares rise after letter to stockholders
May 26Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt
Apr 28Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)
Feb 21How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 19What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?
Dec 15
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$555k | -US$54m |
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$39m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$1m | US$505k | -US$43m |
| Sep 30 2022 | n/a | n/a | -US$83m |
| Jun 30 2022 | n/a | n/a | -US$84m |
| Mar 31 2022 | n/a | n/a | -US$91m |
| Dec 31 2021 | US$2m | US$255k | -US$85m |
Compensación vs. Mercado: La compensación total de Vish($USD2.85M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Vish ha aumentado mientras la empresa no es rentable.
CEO
Vish Seshadri (47 yo)
2.6yrs
Permanencia
US$2,847,442
Compensación
Dr. Vishwas Seshadri, also known as Vish, Ph.D. & M.B.A., serves as Chief Executive Officer, President and Director at Abeona Therapeutics Inc. since October 15, 2021. He served as the Senior Vice Presiden...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 2.6yrs | US$2.85m | 1.97% $ 2.2m | |
| Chief Financial Officer | 2.2yrs | US$1.49m | 0.85% $ 951.8k | |
| Senior VP & General Counsel | 4.1yrs | US$1.17m | 0.69% $ 768.1k | |
| Senior VP | 2.9yrs | sin datos | sin datos | |
| Vice President of Investor Relations & Corporate Communications | no data | sin datos | sin datos | |
| Vice President of Human Resources | 2.3yrs | sin datos | sin datos | |
| VP & Head of Quality | 2.6yrs | sin datos | sin datos | |
| Chief Medical Officer | 1.3yrs | sin datos | sin datos | |
| Senior VP | less than a year | sin datos | sin datos | |
| Senior Vice President of Regulatory Affairs | no data | sin datos | sin datos |
2.5yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de ABEO se considera experimentado (2.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 2.6yrs | US$2.85m | 1.97% $ 2.2m | |
| Independent Director | 3.2yrs | US$336.14k | 0.21% $ 238.9k | |
| Independent Director | 3.2yrs | US$336.14k | 0.29% $ 318.8k | |
| Independent Director | 3.1yrs | US$330.52k | 0.27% $ 306.0k | |
| Independent Director | 4.2yrs | US$324.89k | 0.25% $ 283.7k | |
| Independent Director | 3.1yrs | US$336.14k | 0.25% $ 276.5k | |
| Member of Scientific Advisory Board | 7.1yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 7.1yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 7.1yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 7.1yrs | sin datos | sin datos | |
| Chairman of the Board | 3.2yrs | US$351.14k | 0.29% $ 324.9k |
3.2yrs
Permanencia media
49.5yo
Promedio de edad
Junta con experiencia: La junta directiva de ABEO se considera experimentada (3.1 años de antigüedad promedio).